Qing Lv

700 total citations
40 papers, 476 citations indexed

About

Qing Lv is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Qing Lv has authored 40 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Qing Lv's work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (8 papers) and Breast Implant and Reconstruction (7 papers). Qing Lv is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (8 papers) and Breast Implant and Reconstruction (7 papers). Qing Lv collaborates with scholars based in China, United States and Switzerland. Qing Lv's co-authors include Qiuwen Tan, Jiqiao Yang, Shenli Tang, Jingcong Luo, Francis H. Shen, Gary Balian, Yi Zhang, Xudong Li, Luke Choi and Cato T. Laurencin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Cochrane Database of Systematic Reviews.

In The Last Decade

Qing Lv

39 papers receiving 467 citations

Peers

Qing Lv
Comparison fields: 5 of 84
  • Surgery 191
  • Biomaterials 103
  • Biomedical Engineering 78
  • Oncology 77
  • Molecular Biology 75
Replace Masanobu Mizuta with:
Masanobu Mizuta Japan
Sung‐Chan Shin South Korea
Yuriko Takeuchi Japan
Ashkaun Shaterian United States
Neil Upadhyay United Kingdom
Jin‐Choon Lee South Korea
Weiyan Sun China
Mathew Baldwin United Kingdom
Marina Unger Germany
Masanobu Mizuta Japan View profile →
Citations per field, relative to Qing Lv
Qing Lv · 1×
Citations per year, relative to Qing Lv
Qing Lv · 1×

Countries citing papers authored by Qing Lv

Since Specialization
Citations

This map shows the geographic impact of Qing Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Lv more than expected).

Fields of papers citing papers by Qing Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Lv. The network helps show where Qing Lv may publish in the future.

Co-authorship network of co-authors of Qing Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Lv. A scholar is included among the top collaborators of Qing Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Lv. Qing Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 5
3 3
4 4
5 34
6 14
7 9
8 14
9 8
10 14
11 9
12 4
13 28
14 6
15 34
16
DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma
4
17 1
18 21
19 1
20 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026